Page last updated: 2024-08-26

mafosfamide and Myelodysplastic Syndromes

mafosfamide has been researched along with Myelodysplastic Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Douay, L; Fenaux, P; Gorin, NC; Isnard, F; Laporte, JP; Lesage, S; Lopez, M; Najman, A; Stachowiak, J1
Abdallah, A; Egerer, G; Haas, R; Ho, AD; Körbling, M; Weber-Nordt, RM1

Trials

1 trial(s) available for mafosfamide and Myelodysplastic Syndromes

ArticleYear
Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia.
    Bone marrow transplantation, 2002, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prognosis; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation

2002

Other Studies

1 other study(ies) available for mafosfamide and Myelodysplastic Syndromes

ArticleYear
Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot study.
    Leukemia, 1993, Volume: 7, Issue:12

    Topics: Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Feasibility Studies; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Remission Induction; Transplantation, Autologous

1993